Busca avançada
Ano de início
Entree
(Referência obtida automaticamente do Web of Science, por meio da informação sobre o financiamento pela FAPESP e o número do processo correspondente, incluída na publicação pelos autores.)

Breath Biopsy and Discovery of Exclusive Volatile Organic Compounds for Diagnosis of Infectious Diseases

Texto completo
Autor(es):
Belizario, Jose E. [1] ; Faintuch, Joel [2] ; Malpartida, Miguel Garay [3]
Número total de Autores: 3
Afiliação do(s) autor(es):
[1] Univ Sao Paulo, Inst Biomed Sci, Dept Pharmacol, Sao Paulo - Brazil
[2] Univ Sao Paulo, Sch Med, Dept Gastroenterol, Sao Paulo - Brazil
[3] Univ Sao Paulo, Sch Arts Sci & Humanities EACH, Sao Paulo - Brazil
Número total de Afiliações: 3
Tipo de documento: Artigo de Revisão
Fonte: FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY; v. 10, JAN 7 2021.
Citações Web of Science: 0
Resumo

Exhaled breath contains thousand metabolites and volatile organic compounds (VOCs) that originated from both respiratory tract and internal organ systems and their microbiomes. Commensal and pathogenic bacteria and virus of microbiomes are capable of producing VOCs of different chemical classes, and some of them may serve as biomarkers for installation and progression of various common human diseases. Here we describe qualitative and quantitative methods for measuring VOC fingerprints generated by cellular and microbial metabolic and pathologic pathways. We describe different chemical classes of VOCs and their role in the host cell-microbial interactions and their impact on infection disease pathology. We also update on recent progress on VOC signatures emitted by isolated bacterial species and microbiomes, and VOCs identified in exhaled breath of patients with respiratory tract and gastrointestinal diseases, and inflammatory syndromes, including the acute respiratory distress syndrome and sepsis. The VOC curated databases and instrumentations have been developed through statistically robust breathomic research in large patient populations. Scientists have now the opportunity to find potential biomarkers for both triage and diagnosis of particular human disease. (AU)

Processo FAPESP: 18/24922-8 - Disbiose e imunometabolismo do microbioma intestinal: novas fronteiras para o tratamento de doenças metabólicas
Beneficiário:Humberto Miguel Garay Malpartida
Linha de fomento: Auxílio à Pesquisa - Publicações científicas - Artigo
Processo FAPESP: 07/04513-1 - Papel da nova citocina PANDER na indução de apoptose ou proliferação celular em linhagens tumorais de próstata e de mama
Beneficiário:Humberto Miguel Garay Malpartida
Linha de fomento: Auxílio à Pesquisa - Regular
Processo FAPESP: 15/18647-6 - Human microbiomes and their roles in dysbiosis, common diseases and novel therapeutic approaches
Beneficiário:José Ernesto Belizario
Linha de fomento: Auxílio à Pesquisa - Publicações científicas - Artigo